Bingham Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
941
-24
-2% -$24.5K 0.78% 32
2026
Q1
$888K Sell
965
-37
-4% -$37.5K 0.7% 38
2025
Q4
$1.08M Buy
+1,002
New +$958K 0.93% 29
2025
Q2
$778K Buy
998
+8
+0.8% +$6.22K 0.74% 34
2025
Q1
$818K Sell
990
-79
-7% -$65.7K 0.85% 33
2024
Q4
$825K Buy
+1,069
New +$885K 0.88% 33

Other funds holding LLY

Bingham Private Wealth's LLY Position: Q2 2026 in Review

Bingham Private Wealth reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $24.5K and leaving 941 shares worth $1.13M. The position accounts for 0.78% of the portfolio, ranked #32.

Bingham Private Wealth first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bingham Private Wealth held 941 shares of Eli Lilly worth $1.13M as of Q2 2026.
  • Bingham Private Wealth sold 24 Eli Lilly shares in Q2 2026, an estimated $24.5K.
  • Eli Lilly made up 0.78% of Bingham Private Wealth's portfolio in Q2 2026, its #32 holding.
  • Bingham Private Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bingham Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.